Cargando…
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
In the last decades, the increasing evidence concerning inflammation mechanisms underlying severe eosinophilic asthma has highlighted new potential therapeutic targets and has paved the way to new selective biologic drugs. Understanding the mechanism of action and the clinical outcomes of a particul...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535408/ https://www.ncbi.nlm.nih.gov/pubmed/31190733 http://dx.doi.org/10.2147/BTT.S157183 |